Pt Kalventis Sinergi Farma company information, Employees & Contact Information

Press Release: New Sarclisa subcutaneous formulation met GlobeNewswire

Our Global Manufacturing & Supply Network Sanofi

Việt Nam Administration of Disease Prevention ties up with French vaccine company vietnamnews.vn

Ambien maker Sanofi-Aventis blasts Roseanne Barr: 'Racism is not a known side effect' ABC News - Breaking News, Latest News and Videos

A history of Sanofi pharmaphorum

Sanofi-Aventis plans to close Kansas City plant NBC News

Regeneron, Sanofi-Aventis sue for declaration that dermatitis treatment Dupixent doesn't infringe Amgen patent IPWatchdog.com

Sanofi-Aventis, parent of Monroe County's Sanofi Pasteur, buys Genzyme for $20 billion lehighvalleylive

Drug Maker Sanofi-Aventis to Buy Genzyme for $20B CBS News

Sanofi-Aventis launches Genzyme takeover battle Cleveland.com

Reports: Genzyme Inks Merger Deal With Sanofi-Aventis WBUR

Sanofi-Aventis hostile takeover rumours Expatica

Sanofi-Aventis Korea to focus on developing biologic products koreabiomed.com

Sanofi-Aventis goes hostile in battle for Genzyme The Guardian

Sanofi-aventis and Nichi-Iko announce joint venture for generics in Japan Generics and Biosimilars Initiative

Sanofi-Aventis Licenses Intelliject’s Epinephrine Auto-Injector for $25M Up Front Genetic Engineering and Biotechnology News

Time capsule: Sanofi-Aventis acquired Chattem in 2009 for $1.9 billion Chattanooga Times Free Press

Sanofi-Aventis to lay off 1,700 in U.S. lehighvalleylive

Genzyme Sold To Sanofi-Aventis In $20 Billion Deal CBS News

Sanofi launches hostile bid for Aventis NBC News

Sanofi-Aventis buys Genzyme for $20.1 billion NJ.com

Sanofi-Aventis unveils state-of-art research facility Inside Tucson Business

Sanofi-Aventis CEO spoke too soon about capacity to make flu vaccine in Swiftwater Pocono Record

Philippines: union actions at Sanofi Aventis lead to collective bargaining agreement IndustriALL

Expert Statement: Matthias Braun, Sanofi-Aventis Germany CHEManager

Unionized workers sue Sanofi Aventis Korea for unpaid overtime wages koreabiomed.com

‘Sanofi squanders cash to settle unfair layoffs, disciplines’ koreabiomed.com

Genzyme Rejects Sanofi Offer, Long Battle Looms CHEManager

Sanofi presents next-generation basal insulin Toujeo The Korea Herald

Kalbe Farma Owned By Conglomerate Boenjamin Setiawan Ties Sale And Purchase Agreement Of 80 Percent Shares Of Pharmaceutical Company From France VOI.ID

Bristol-Myers Squibb, Sanofi to pay Hawaii $916M over Plavix resistance risks Class Action Lawsuits

10 Top-Selling Drugs Coming Off Patent ABC News - Breaking News, Latest News and Videos

A look back at Sanofi’s merger with Synthélabo PMLiVE

Merck sells its 50% of Merial to Sanofi-Aventis Pig Progress

Third Circuit: Unsecured Claim for Royalties from Intellectual Property Purchased by Debtor Discharged Under Chapter 11 Plan Jones Day

Sanofi Aventis Foundation prizes for MedUni Vienna researchers MedUni Wien

What is Ambien and what are its known side effects? ABC News - Breaking News, Latest News and Videos

Sanofi-Aventis to buy Genzyme in search for new sales BBC

ZenithOptimedia on alert as Sanofi-Aventis calls review Campaign

Sanofi-Aventis to acquire Israeli healthcare products co Globes - Israel Business News

Sanofi’s exit plan baffles employees The Daily Star

Rebecca Bliefnick Obituary (2023) - Quincy, IL - Herald-Whig Legacy obituary

Aventis Pharma renamed as Sanofi India Moneycontrol

Sanofi brings out Cenovis brand The Korea Times

Sanofi is a multinational pharmaceutical company whose headquarters are currently based in Paris, France. diabetes.co.uk

Sanofi Quits Nigeria, Hands Over Operations to Third Party Business Post Nigeria

Sanofi-Aventis: Packages-led consortium acquires full 52.87pc stake held by Sanofi Foreign Business Recorder

Pharma company Sanofi-Aventis Pakistan changes name to Hoechst Pakistan Limited Business Recorder

Families denied legal aid for epilepsy drug court case BBC

Sanofi Aventis Pakistan Limited Business Recorder

French pharmaceutical firm, Sanofi-Aventis to end direct operations in Nigeria over economic situation thestreetjournal.org